Medicare Enrolled

Dr. Abdallah Jeroudi, MD

Ophthalmology · Jacksonville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
2639 OAK ST, Jacksonville, FL 32204
9043875600
In practice since 2011 (14 years)
NPI: 1730479650 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jeroudi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jeroudi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jeroudi

Dr. Abdallah Jeroudi is an ophthalmology in Jacksonville, FL, with 14 years in practice. Based on federal Medicare data, Dr. Jeroudi performed 30,306 Medicare services across 5,198 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jeroudi received a total of $4,251 from 11 pharmaceutical and/or device companies across 49 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jeroudi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 5% volume in FL$ $4,251 industry payments

Medicare Practice Summary

Medicare Utilization ↗
30,306
Medicare services
Top 5% in FL for ophthalmology
5,198
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,165 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)17,701$29$79
Aflibercept eye injection (Eylea)3,164$680$1,703
Retinal imaging (OCT scan)2,793$30$77
Eye injection for retinal disease2,113$95$452
Comprehensive eye exam, established patient998$89$230
Retinal photography (fundus photo)837$27$126
Extended exam of the back part of the eye with optic nerve drawing521$11$80
Eye exam, established patient, focused496$68$178
Compounded drug, not otherwise classified363$64$305
New patient office visit (45-59 min)345$123$334
Injection, ranibizumab, 0.1 mg331$175$605
Office visit, established patient (20-29 min)254$62$144
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg230$216$988
Unclassified drugs76$375$1,291
2d ultrasound scan of eye tissue and structures32$38$226
Not otherwise classified, antineoplastic drugs23$67$309
Destruction of leaking blood vessels of retina using laser16$245$1,970
Photocoagulation treatment to prevent detachment of retina13$170$1,193
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,251
Total received (2018-2024)
Avg $607/year across 7 years
Top 29% in FL for ophthalmology
11
Companies
49
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$1,663 (39.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,459 (34.3%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$1,130 (26.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$410
2023
$2,104
2022
$552
2021
$293
2020
$180
2019
$494
2018
$218

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
US Retina LLC
$2,792
Regeneron Healthcare Solutions, Inc.
$552
Astellas Pharma US Inc
$154
Novartis Pharmaceuticals Corporation
$151
Genentech USA, Inc.
$139
Allergan Inc.
$130
Coherus Biosciences Inc.
$119
Bausch & Lomb Americas Inc.
$102
Alimera Sciences, Inc.
$66
Apellis Pharmaceuticals, Inc.
$33
Mallinckrodt Hospital Products Inc.
$13
Top 3 companies account for 82.3% of total payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · Cimerli · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · Izervay · OZURDEX · Syfovre · VABYSMO · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type.

Equivalent to $14 per 100 Medicare services performed
Looking for a ophthalmology in Jacksonville?
Compare ophthalmologys in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
97
Per 100K population
9.6
County median income
$68,447
Nearest hospital
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jeroudi is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and mixed engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Jeroudi experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Jeroudi performed 17,701 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jeroudi receive payments from pharmaceutical companies?
Yes. Dr. Jeroudi received a total of $4,251 from 11 companies across 49 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jeroudi's costs compare to other ophthalmologys in Jacksonville?
Dr. Jeroudi's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jeroudi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →